Latest Stock Market News

The pandemic-induced rally in the stock market led to explosive growth in the number of demat accounts, with many novice investors trading recklessly on the basis of ads offering "trading as a profession." However, the vast majority of retail investors do not get good returns from the market because they invest in cheap low-grade stocks and do not conduct research. Moreover, the vast majority of traders lose money in reckless overtrading, with a recent SEBI study finding that 89% of traders in the equity F&O segment lost money in FY22. Only disciplined, systematic investment in high-quality stocks/mutual funds can result in good returns over the long term.

Axis Bank’s Q4 earnings are expected to be impacted by the one-off costs due to the integration of Citibank India’s business, leading to net losses, according to some analysts. The estimated net loss ranges from INR 54.12bn to INR 55.26bn, while others have excluded the integration costs from their calculations. The bank’s strong core performance is projected despite one-off costs, led by high double-digit growth in net interest income, lower bad loans, and net interest margin. Key items to watch from the management include business plans, near-term growth trends, and margin trajectory.

​There are other parts of the emerging markets universe where you are actually getting superior growth outlook for the next couple of years at far compelling valuations. So yes, we still have India as an underweight in our EM universe.

Shares of Gland Pharma were up 0.8% at 1,360 rupees as of 9:50 a.m. IST. They have plunged 28% since November end, when Bloomberg News had reported, citing sources that Fosun Pharma was considering a sale of Gland Pharma after receiving interest from potential buyers.

The Nifty Bank index was trading 0.15 per cent down at 42615.65.

On the technical charts, the RSI of the stock stood at 50.33.

So far in 2023, Indian equity indices Nifty and Sensex have declined 2% and 1.3%, respectively as FIIs have sold stocks worth over Rs 19,000 crore this year. Meanwhile, major global markets have risen up to 17% year-to-date.

Deepak Shenoy believes that larger cap companies in India will eventually recover as their core business is attractive and they have no debt and the ability to expand. However, in the short term, stocks will not do well. The new age companies face selling pressure from insiders and venture capitalists, and the charisma of a leader can affect motivation and the stock price.

"Data on US inflation and GDP expected this week will have an impact on global markets and on India, too. Results of US tech majors have been good. If the US disinflation trend indicates a steady decline, that can be positive trigger for equity markets globally," V K Vijayakumar, Chief Investment Strategist at Geojit Financial Services, said.

Experts recommend investing in infrastructure stocks like L&T, RVNL, and IRCON for a long-term basis, due to the increasing number of government contracts flowing their way. ABB also predicts a 46% YoY increase in Indian order flows. However, experts urge investors to be cautious of the high volatility of these stocks, with a possible downside of 25-30%. While